glp 1 receptor agonists incretin mimetics Incretin-Based Therapies Through the Decades: Molecular Innovations and Clinical Impact You might've heard of this
Description
Other than direct consequences, such as degenerative arthritis and sleep apnea, its controversial whether being overweight in and of itself causes a health risk
The results seem to be better with once-weekly administered GLP-1 RAs compared to those requiring once-daily injections [26,27,28]
CNS Drugs 29, 10231039
PMCID: PMC4141528 ) Aster RH, Curtis BR, McFarland JG, Bougie DW (2009) Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management
Pederson RA, Brown JC
Being obese with a body mass index of over 25 kg/m also increases the risk of diabetes
